G01N 2800/709
Toxin induced
G01N2800/709 (Toxin induced) appears on 39 US grants and 60 published applications in this corpus.
Search patents in G01N- Granted patents
- 39
- Published applications
- 60
- Assignees
- 52
- Inventors
- 125
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 3 | 6 |
| 2015 | 2 | 7 |
| 2016 | 6 | 6 |
| 2017 | 2 | 4 |
| 2018 | 3 | 4 |
| 2019 | 3 | 4 |
| 2020 | 5 | 7 |
| 2021 | 5 | 6 |
| 2022 | 2 | 2 |
| 2023 | 2 | 2 |
| 2024 | 4 | 3 |
| 2025 | 0 | 3 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Anti-human-IL-1-βantibodies, encoding nucleic acids thereof and methods of using thereof to treat inflammatory diseases and cancer20 Jan 2026US 12,528,861 B2Eli Lilly and Company
- Tetrathionate for cyanide and methylmercaptan poisoning10 Dec 2024US 12,161,664 B2The Regents of the University of California
- Acetaminophen adducts and methods of use thereof21 May 2024US 11,987,834 B2BioVentures, LLC
- Vagus nerve stimulation pre-screening test6 Feb 2024US 11,890,471 B2SetPoint Medical Corporation
- Means and methods for the determination of the biological activity of BoNT/E in cells16 Jan 2024US 11,874,273 B2MERZ PHARMA GmbH & CO. KGaA
- Cell Based Assays for Botulinum2 Apr 2026US 2026/0092255 A1BioMadison, Inc.
- Development of a multiplexing Biosensing platform for the simultaneous detection of Snake and Scorpion venoms27 Mar 2025US 2025/0102518 A1Alfaisal University
- Cell-based method for determining an activity of botulinum toxin6 Feb 2025US 2025/0044281 A1Hugel Inc.
- Diagnostic and therapeutic methods using heme as a biomarker for cellular and tissue damage23 Jan 2025US 2025/0027958 A1Beth Israel Deaconess Medical Center, Inc.
- Acetaminophen protein adducts and methods of use thereof7 Nov 2024US 2024/0368669 A1BioVentures, LLC
Most cited
By later US patents
- Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use18US 9,527,905 B2MedImmune, LLC · 2016
- Vagus nerve stimulation pre-screening test17US 11,173,307 B2SetPoint Medical Corporation · 2021
- Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto10US 9,194,867 B2Cyrex Laboratories, LLC · 2015
- Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto9US 8,663,911 B2Cyrex Laboratories, LLC · 2014
- Compositions and methods for enhancing metal ion dependent drug therapies5US 8,591,884 B2CNSS IP Holdings, Inc. · 2013